Waypoint Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $396K | Hold |
4,006
| – | – | 0.08% | 96 |
|
|
2024
Q2 | $371K | Buy |
4,006
+5
| +0.1% | +$464 | 0.09% | 95 |
|
|
2024
Q1 | $380K | Hold |
4,001
| – | – | 0.1% | 92 |
|
|
2023
Q4 | $357K | Buy |
4,001
+1
| +0% | +$89 | 0.1% | 94 |
|
|
2023
Q3 | $292K | Hold |
4,000
| – | – | 0.1% | 100 |
|
|
2023
Q2 | $333K | Hold |
4,000
| – | – | 0.1% | 107 |
|
|
2023
Q1 | $305K | Hold |
4,000
| – | – | 0.1% | 114 |
|
|
2022
Q4 | $332K | Hold |
4,000
| – | – | 0.12% | 107 |
|
|
2022
Q3 | $317K | Hold |
4,000
| – | – | 0.14% | 90 |
|
|
2022
Q2 | $297K | Buy |
+4,000
| New | +$297K | 0.13% | 92 |
|